Haematology Oncology Strong — validated in 10,750 patients from 17 institutions; endorsed by IMWG
International Staging System (ISS) for Multiple Myeloma
Predicts overall survival in multiple myeloma using serum β2-microglobulin and albumin. Simple and reproducible staging system used alongside cytogenetics.
References
- Greipp PR, et al. International staging system for multiple myeloma. J Clin Oncol. 2005;23(15):3412–3420.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Noradrenaline (Norepinephrine) · Vasopressor (Alpha-1 and Beta-1 Agonist)
- Dobutamine (ICU — Inotrope) · Inotrope (Beta-1 Agonist)
- Labetalol (IV — Hypertensive Emergency) · Combined Alpha-1 and Beta-Adrenergic Blocker
- Ephedrine hydrochloride · Mixed alpha/beta-adrenergic agonist (vasopressor)
- Sotalol · Antiarrhythmic
- Metoprolol (IV/Oral — Cardiology) · Beta-Blocker
Pathways
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE
- Deep Vein Thrombosis Diagnosis and Treatment · NICE CG144 / NICE NG158
- Sickle Cell Crisis · BSH 2021 / BCSH
- Neutropenic Sepsis · NICE CG151 2012 / ESMO
- Anticoagulation Reversal · BSH 2016 / ESC
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.